| scholarly article | Q13442814 |
| P2093 | author name string | D M Small | |
| M G Bond | |||
| D Waugh | |||
| J K Sawyer | |||
| M Prack | |||
| P2860 | cites work | A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 |
| Receptor-Mediated Control of Cholesterol Metabolism | Q28297251 | ||
| The physicochemical basis of cholesterol gallstone formation in man. | Q34275014 | ||
| Lipid droplets in atherosclerotic fatty streaks of human aorta | Q35579213 | ||
| A study of atherosclerosis regression in Macaca mulatta: III. Chemical changes in arteries from animals with atherosclerosis induced for 19 months and regressed for 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl | Q35863324 | ||
| Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques | Q35902742 | ||
| Studies on the Structure of Low Density Lipoproteins Isolated from Macaca Fascicularis Fed an Atherogenic Diet | Q37034387 | ||
| The storage lipids in Tangier disease. A physical chemical study | Q37044716 | ||
| Cellular mechanisms for lipid deposition in atherosclerosis (first of two parts). | Q37623445 | ||
| A study of atherosclerosis regression in Macaca mulatta. I. Design of experiment and lesion induction | Q39665150 | ||
| Atherosclerotic plaque regression in rhesus monkeys induced by bile acid sequestrant | Q39699090 | ||
| Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins | Q40210370 | ||
| The phase behavior of hydrated cholesterol | Q41689601 | ||
| Significance of cholesterol esters as liquid crystal in human atherosclerosis. | Q53757202 | ||
| Cholesterol turnover in lipid phases of human atherosclerotic plaque. | Q54515082 | ||
| The microdissection of large atherosclerotic plaques to give morphologically and topographically defined fractions for analysis *1Part 1. The lipids in the isolated fractions | Q67299859 | ||
| Depletion of aortic free and ester cholesterol by dietary means in rhesus monkeys with fatty streaks | Q67508670 | ||
| Studies of regression of advanced atherosclerosis in experimental animals and man | Q67531404 | ||
| The gross and histologic appearance and the lipid composition of normal intima and lesions from human coronary arteries and aorta | Q68893598 | ||
| Physical-Chemical Basis of Lipid Deposition in Atherosclerosis | Q69778548 | ||
| Lipid Depletion in Atheromatous Coronary Arteries in Rhesus Monkeys after Regression Diets | Q70372274 | ||
| A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl | Q70793807 | ||
| Complicating factors in evaluating coronary artery atherosclerosis | Q70818774 | ||
| The lipids or grossly normal human aortic intima from birth to old age | Q70976008 | ||
| Cholesterol nucleation and growth in gallstone formation | Q71167018 | ||
| Isolation and and partial characterization of the lipid phases of human atherosclerotic plaques | Q71364239 | ||
| Lipid changes in atherosclerotic aortas of Macaca fascicularis after various regression regimens | Q71467395 | ||
| A study of atherosclerosis regression in Macaca mulatta. II. Chemical changes in arteries from animals with atherosclerosis induced for 19 months then regressed for 24 months at plasma cholesterol concentrations of 300 or 200 mg/dl | Q71497017 | ||
| Photodensitometry in the thin-layer chromatographic analysis of neutral lipids | Q72129332 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1590-1605 | |
| P577 | publication date | 1984-06-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis | |
| P478 | volume | 73 |
| Q37268111 | A cerebrovascular perspective of atherosclerosis |
| Q38363238 | ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity |
| Q43752274 | Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux |
| Q36675401 | Analysis of angiographic trial data in women. |
| Q44895988 | Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol |
| Q34333582 | Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis |
| Q33613217 | Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events |
| Q37786650 | Atherosclerosis regression and high-density lipoproteins |
| Q40872795 | Atherosclerosis: what is it and why does it occur? |
| Q77516271 | Atherosclerotic plaque assessment by NMR |
| Q53424003 | Carotid thin fluttering bands: A new element of arterial wall remodelling? An ultrasound study. |
| Q35615787 | Celery Seed Extract Blocks Peroxide Injury in Macrophages via Notch1/NF-κB Pathway |
| Q50494313 | Cholesterol accumulation inhibits ER to Golgi transport and protein secretion: studies of apolipoprotein E and VSVGt. |
| Q34101231 | Cholesterol and phospholipid metabolism in macrophages |
| Q33538129 | Cholesterol lowering and coronary artery disease: mechanisms of risk reduction. |
| Q46870067 | Cholesterol-induced apoptotic macrophages elicit an inflammatory response in phagocytes, which is partially attenuated by the Mer receptor |
| Q36320445 | Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor |
| Q36955987 | Chronic miR-29 antagonism promotes favorable plaque remodeling in atherosclerotic mice |
| Q38394212 | Concentration-Dependent Diversifcation Effects of Free Cholesterol Loading on Macrophage Viability and Polarization |
| Q40459835 | Coronary Plaque Disruption |
| Q73809234 | Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris--an intravascular ultrasound study |
| Q35062347 | Coronary arterial remodeling: from bench to bedside |
| Q93158334 | Cytokine Circuits in Cardiovascular Disease |
| Q73112112 | Different effects of hypertension and hypercholesterolemia on the natural history of aortic atherosclerosis by the stage of intimal lesions |
| Q42248566 | Endoplasmic reticulum stress-related inflammation and cardiovascular diseases |
| Q40542044 | Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and a |
| Q47772630 | Free cholesterol-induced cytotoxicity a possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions |
| Q46434986 | Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis |
| Q35501068 | Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults |
| Q35563460 | Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis |
| Q37603218 | IL-22 is induced by S100/calgranulin and impairs cholesterol efflux in macrophages by downregulating ABCG1 |
| Q52533072 | Importance of endothelial function in mediating the benefits of lipid-lowering therapy. |
| Q91587778 | Lipid-Rich Necrotic Core of Basilar Artery Atherosclerotic Plaque: Contrast-Enhanced Black Blood Imaging on Vessel Wall Imaging |
| Q36733402 | Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice |
| Q36800049 | MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course |
| Q52540500 | Macrophages deficient in CTP:Phosphocholine cytidylyltransferase-alpha are viable under normal culture conditions but are highly susceptible to free cholesterol-induced death. Molecular genetic evidence that the induction of phosphatidylcholine bios |
| Q74823705 | New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease |
| Q35918384 | Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis |
| Q57635945 | Non-invasive management of coronary artery disease |
| Q46400608 | Oral supplement of six selective amino acids arrest progression renal failure in uremic patients |
| Q36502796 | Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia |
| Q28195433 | Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective |
| Q41386371 | Pathophysiology of plaque rupture and the concept of plaque stabilization |
| Q34129645 | Phase behavior and crystalline structures of cholesteryl ester mixtures: a C-13 MASNMR study |
| Q40890532 | Primary prevention of coronary heart disease. What has WOSCOPS told us and what questions remain? West Of Scotland Coronary Prevention Study. |
| Q36383197 | Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets |
| Q40843724 | Quantitative analysis of cholesterol and cholesteryl esters in human atherosclerotic plaques using near-infrared Raman spectroscopy |
| Q34774208 | Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging |
| Q46304032 | Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction |
| Q33607199 | Regression of atherosclerosis--an ounce of prevention. |
| Q34490926 | Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin |
| Q50779446 | Reversal of gangrenous lesions in the blue toe syndrome with lovastatin--a case report. |
| Q42578006 | Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content |
| Q41785863 | Spontaneous formation of two-dimensional and three-dimensional cholesterol crystals in single hydrated lipid bilayers |
| Q34876397 | Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression |
| Q41846994 | Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice |
| Q38137848 | Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease |
| Q44542540 | The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages |
| Q34761170 | The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis |
| Q33671919 | Thrombosis and coagulation abnormalities in the acute coronary syndromes |
| Q44570970 | Unfolding the toxicity of cholesterol. |
| Q36422755 | Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy |
| Q40421178 | What benefit can be derived from treating normocholesterolemic patients with coronary artery disease? |
| Q33607440 | Why are low-density lipoproteins atherogenic? |
| Q74564754 | [Pathomorphology of coronary atherosclerosis] |
Search more.